300 related articles for article (PubMed ID: 27998715)
1. Diagnostic algorithm for familial chylomicronemia syndrome.
Stroes E; Moulin P; Parhofer KG; Rebours V; Löhr JM; Averna M
Atheroscler Suppl; 2017 Jan; 23():1-7. PubMed ID: 27998715
[TBL] [Abstract][Full Text] [Related]
2. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".
Moulin P; Dufour R; Averna M; Arca M; Cefalù AB; Noto D; D'Erasmo L; Di Costanzo A; Marçais C; Alvarez-Sala Walther LA; Banach M; Borén J; Cramb R; Gouni-Berthold I; Hughes E; Johnson C; Pintó X; Reiner Ž; van Lennep JR; Soran H; Stefanutti C; Stroes E; Bruckert E
Atherosclerosis; 2018 Aug; 275():265-272. PubMed ID: 29980054
[TBL] [Abstract][Full Text] [Related]
3. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
Falko JM
Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397
[TBL] [Abstract][Full Text] [Related]
4. Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.
Marco-Benedí V; Lamiquiz-Moneo I; Álvarez-Sala LA; Civeira F
Atherosclerosis; 2018 Aug; 275():342-345. PubMed ID: 30015297
[TBL] [Abstract][Full Text] [Related]
5. Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment.
Gallo A; Béliard S; D'Erasmo L; Bruckert E
Curr Atheroscler Rep; 2020 Aug; 22(11):63. PubMed ID: 32852651
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
Caddeo A; Mancina RM; Pirazzi C; Russo C; Sasidharan K; Sandstedt J; Maurotti S; Montalcini T; Pujia A; Leren TP; Romeo S; Pingitore P
Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):158-164. PubMed ID: 29288010
[TBL] [Abstract][Full Text] [Related]
7. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis.
Chyzhyk V; Brown AS
Trends Cardiovasc Med; 2020 Feb; 30(2):80-85. PubMed ID: 31003756
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia.
Rabacchi C; Pisciotta L; Cefalù AB; Noto D; Fresa R; Tarugi P; Averna M; Bertolini S; Calandra S
Atherosclerosis; 2015 Jul; 241(1):79-86. PubMed ID: 25966443
[TBL] [Abstract][Full Text] [Related]
9. Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion.
Santos RD; Lorenzatti A; Corral P; Nogueira JP; Cafferata AM; Aimone D; Lourenço CM; Izar MC; Lima JG; Lottenberg AM; Alonso R; Garay K; Morales AR; Vargas-Uricoechea H; Peña CAC; Roman-González A
J Clin Lipidol; 2021; 15(5):620-624. PubMed ID: 34920815
[TBL] [Abstract][Full Text] [Related]
10. Molecular and functional characterization of familial chylomicronemia syndrome.
Teramoto R; Tada H; Kawashiri MA; Nohara A; Nakahashi T; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
Atherosclerosis; 2018 Feb; 269():272-278. PubMed ID: 29153744
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes.
D'Erasmo L; Di Costanzo A; Cassandra F; Minicocci I; Polito L; Montali A; Ceci F; Arca M
Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2531-2541. PubMed ID: 31619059
[TBL] [Abstract][Full Text] [Related]
12. Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome.
Rioja J; Ariza MJ; Benítez-Toledo MJ; Espíldora-Hernández J; Coca-Prieto I; Arrobas-Velilla T; Camacho A; Olivecrona G; Sánchez-Chaparro MÁ; Valdivielso P
J Clin Lipidol; 2023; 17(2):272-280. PubMed ID: 36813655
[TBL] [Abstract][Full Text] [Related]
13. The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
Chait A; Eckel RH
Ann Intern Med; 2019 May; 170(9):626-634. PubMed ID: 31035285
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D
J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148
[TBL] [Abstract][Full Text] [Related]
15. Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia.
Paquette M; Bernard S; Hegele RA; Baass A
Atherosclerosis; 2019 Apr; 283():137-142. PubMed ID: 30655019
[TBL] [Abstract][Full Text] [Related]
16. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study.
Rodriguez FH; Estrada JM; Quintero HMA; Nogueira JP; Porras-Hurtado GL
Lipids Health Dis; 2023 Mar; 22(1):43. PubMed ID: 36978188
[TBL] [Abstract][Full Text] [Related]
17. Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome.
Zhang Y; Zhou J; Zheng W; Lan Z; Huang Z; Yang Q; Liu C; Gao R; Zhang Y
Lipids Health Dis; 2016 May; 15():88. PubMed ID: 27153815
[TBL] [Abstract][Full Text] [Related]
18. Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report.
Lin MH; Tian XH; Hao XL; Fei H; Yin JL; Yan DD; Li T
BMC Pregnancy Childbirth; 2020 May; 20(1):272. PubMed ID: 32375710
[TBL] [Abstract][Full Text] [Related]
19. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene.
Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ
BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573
[TBL] [Abstract][Full Text] [Related]
20. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.
Davidson M; Stevenson M; Hsieh A; Ahmad Z; Roeters van Lennep J; Crowson C; Witztum JL
J Clin Lipidol; 2018; 12(4):898-907.e2. PubMed ID: 29784572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
